Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Kidney Neoplasms × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 3 Vaginal Neoplasms 2 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Neuroendocrine Tumors 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Accelerated Phase 1 Gallbladder Neoplasms 1 Blast Crisis 1

Interventions

Sunitinib 16 Everolimus 15 Bevacizumab 12 aldesleukin 10 Sorafenib 10 Cyclophosphamide 10 Nivolumab 9 Interleukin-2 9 fludarabine phosphate 7 fludarabine 7 Axitinib 7 Gemcitabine 5 temsirolimus 4 pembrolizumab 4 pazopanib 4 Ipilimumab 4 peginterferon alfa-2b 3 durvalumab 3 Radiosurgery 3 Interferon-alpha 3 Filgrastim 3 Erlotinib Hydrochloride 3 Cryosurgery 3 vandetanib 2 perflutren 2 ixabepilone 2 chiron 2 carfilzomib 2 cabozantinib 2 belzutifan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡